Menu
Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,459 | Dovepress* | 6,531+ | 1,494 | 8,025 | |
| PubMed Central* | 928 | 347 | 1,275 | ||
| Totals | 7,459 | 1,841 | 9,300 | ||
|
*Since 24 February 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar